We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
-4.09%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$2.52B
AUM Growth
-$173M
(-6.4%)
Cap. Flow
-$49.2M
Cap. Flow
% of AUM
-1.95%
Top 10 Holdings %
Top 10 Hldgs %
37.25%
Holding
3,473
New
218
Increased
908
Reduced
1,467
Closed
292
Avg Time Held Equity + Options
3
years
Top 10 Avg Time Held Equity + Options
2.4
years
Top 20 Avg Time Held Equity + Options
2.4
years
Avg Time Held Equity only
3
years
Top 10 Avg Time Held Equity only
2.4
years
Top 20 Avg Time Held Equity only
2.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Fallen Angels USD Bond ETF
FALN
|
+$9.31M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$6.87M |
| 3 |
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
|
+$3.6M |
| 4 |
Corcept Therapeutics
CORT
|
+$3M |
| 5 |
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
|
+$2.68M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard ESG US Stock ETF
ESGV
|
+$9.63M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$7.01M |
| 3 |
Microsoft
MSFT
|
+$5.41M |
| 4 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$5.16M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$4.44M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 51.1% |
| 2 | Technology | 15.39% |
| 3 | Financials | 8.2% |
| 4 | Healthcare | 7.16% |
| 5 | Consumer Discretionary | 5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3151
Mistras Group
MG
$659M
| $0 | ﹤0.01% |
77
| – | – |
2021 Q3
2 quarters
|
|
3152
Movado Group
MOV
$740M
| – | – |
-51
| Closed | -$2K | – |
|
3153
DELISTED
Mersana Therapeutics
MRSN
| – | – |
-51
| Closed | -$8K | – |
|
3154
Meritage Homes
MTH
$3.93B
| – | – |
-178
| Closed | -$11K | – |
|
3155
Materion
MTRN
$5.25B
| $0 | ﹤0.01% |
2
-51
| -96% | -$4.36K |
2021 Q4
1 quarter
|
|
3156
Manitowoc
MTW
$809M
| $0 | ﹤0.01% |
+6
| New | +$103 |
2022 Q1
0 quarters
|
|
3157
Microvast
MVST
$219M
| $0 | ﹤0.01% |
30
| – | – |
2021 Q1
4 quarters
|
|
3158
Mueller Water Products
MWA
$3.38B
| – | – |
-102
| Closed | -$1K | – |
|
3159
iShares Global Materials ETF
MXI
$435M
| $0 | ﹤0.01% |
5
| – | – |
2021 Q2
3 quarters
|
|
3160
MaxLinear
MXL
$7.09B
| $0 | ﹤0.01% |
+3
| New | +$183 |
2022 Q1
0 quarters
|
|
3161
Myers Industries
MYE
$1.17B
| – | – |
-5
| Closed | – | – |
|
3162
Nature's Sunshine
NATR
$222M
| – | – |
-95
| Closed | -$2K | – |
|
3163
Nabors Industries
NBR
$1.16B
| – | – |
-27
| Closed | -$2K | – |
|
3164
NuCana
NCNA
$4.25M
| – | – |
-1
| Closed | -$12K | – |
|
3165
New Fortress Energy
NFE
$23.9M
| – | – |
0
| – | – |
2021 Q4
1 quarter
|
|
3166
Nkarta
NKTX
$138M
| – | – |
-66
| Closed | -$1K | – |
|
3167
Northern Oil and Gas
NOG
$2.74B
| – | – |
-523
| Closed | -$11K | – |
|
3168
NRC Health Common Stock
NRC
$467M
| – | – |
-11
| Closed | – | – |
|
3169
Nurix Therapeutics
NRIX
$2.73B
| – | – |
-9
| Closed | – | – |
|
3170
Napco Security Technologies
NSSC
$1.29B
| – | – |
-32
| Closed | -$1K | – |
|
3171
NETSTREIT Corp
NTST
$1.76B
| $0 | ﹤0.01% |
9
| – | – |
2021 Q3
2 quarters
|
|
3172
NVE Corp
NVEC
$502M
| – | – |
-57
| Closed | -$4K | – |
|
3173
Obsidian Energy
OBE
$765M
| $0 | ﹤0.01% |
+8
| New | +$63 |
2022 Q1
0 quarters
|
|
3174
Ocular Therapeutix
OCUL
$1.62B
| – | – |
-1,012
| Closed | -$7K | – |
|
3175
Organigram Holdings
OGI
$134M
| $0 | ﹤0.01% |
33
| – | – |
2019 Q3
10 quarters
|
|
Similar funds
Parallel Advisors's Q1 2022 Portfolio in Review
As of Q1 2022, Parallel Advisors held 3,473 positions worth $2.52B, down 6.4% from $2.69B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Parallel Advisors's Q1 2022 filing shows 218 new, 908 increased, 1,467 reduced and 292 closed positions. Its largest new stake was eFFECTOR Therapeutics, Inc. Common Stock: 27,098 shares worth $2.74M. The largest sale was Vanguard ESG US Stock ETF, an estimated $9.63M.
By sector, the portfolio is most concentrated in Miscellaneous at 51% of assets, down from 51% a quarter earlier, followed by Technology and Financials.
- Parallel Advisors's largest Q1 2022 buy was eFFECTOR Therapeutics, Inc. Common Stock: 27,098 shares worth $2.74M.
- Parallel Advisors added most to iShares Fallen Angels USD Bond ETF in Q1 2022, an estimated $9.31M increase.
- Parallel Advisors's biggest Q1 2022 reduction was Vanguard ESG US Stock ETF, cutting an estimated $9.63M.
- Parallel Advisors fully exited State Street SPDR Nuveen ICE Short Term Municipal Bond ETF in Q1 2022, selling an estimated $1.09M.
- Parallel Advisors's ten largest holdings make up 37% of its $2.52B portfolio in Q1 2022.
- Parallel Advisors opened 218 new positions and closed 292 in Q1 2022.
- Parallel Advisors's portfolio value fell 6.4% quarter-over-quarter to $2.52B.
Based on Parallel Advisors's 13F filing for Q1 2022, filed 28 Apr 2022.